Major Pharmaceuticals recalls
Major Pharmaceuticals has 19 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 29 Jul 2026. 12 are still ongoing. 12 were reported in the last 12 months. The most frequent reason is potency & assay.
Total recalls 19 since 2018
Last 12 months 12 reported
Class I 0 0% of total
Ongoing 12 latest 29 Jul 2026
Recalls per month, last 24 months click a bar for that month Severity split
0 0%17 89%2 11%
Why major pharmaceuticals is recalled
Ongoing major pharmaceuticals recalls 12 active Reported Class Recall Company Reason Where 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg) recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 50 mcg recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg) recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg) recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 25 mcg recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg) recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide
All major pharmaceuticals recalls, newest first 19 total Reported Class Recall Company Reason Where 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg) recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 50 mcg recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg) recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg) recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 25 mcg recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg) recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 125 mcg recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 150 mcg recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 29 Jul 2026 Drug CLASS II Levothyroxine Sodium Tablets, USP, 75 mcg recalled Levothyroxine Sodium Major Pharmaceuticals Potency & Assay Nationwide 7 Aug 2019 Drug CLASS II Divalproex Sodium Extended-release Tablets, USP Tablets recalled Divalproex Sodium Major Pharmaceuticals Manufacturing (CGMP) Deviations Nationwide 17 Jul 2019 Drug CLASS II Losartan Potassium Tablets recalled by Major Pharmaceuticals Major Pharmaceuticals Nitrosamine Impurity Nationwide 8 Aug 2018 Drug CLASS II Doxycycline Hyclate Tablets, USP, 100 mg recalled Doxycycline Hyclate Major Pharmaceuticals Potency & Assay Nationwide 1 Aug 2018 Drug CLASS II Unit Dose Valsartan Tablets recalled by Major Pharmaceuticals Major Pharmaceuticals Potency & Assay Nationwide 1 Aug 2018 Drug CLASS III Enalapril Maleate Tablets, USP, 2.5 mg Dose recalled Major Pharmaceuticals Potency & Assay Nationwide 1 Aug 2018 Drug CLASS II Unit Dose Valsartan Tablets, USP, 80 mg recalled Major Pharmaceuticals Potency & Assay Nationwide 1 Aug 2018 Drug CLASS III Enalapril Maleate Tablets, USP, 5 mg Dose recalled Major Pharmaceuticals Potency & Assay Nationwide
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.